Cernuda-Morollón E, Pérez-Sala D [2006]. Regulation of proinflammatory transcription factors by direct modification with cyclopentenone prostaglandins. Eds: Woods CR. Trends in DNA Research. Nova Science Publishers, Inc. New York pp 1-31
Gayarre J, Stamatakis K, Renedo M, Pérez-Sala D [2005]. Differential selectivity of protein modification by the cyclopentenone prostaglandins PGA1 and 15-deoxy-D12,14-PGJ2: role of glutathione. FEBS Lett 579:5803-5808.
Stamatakis K, Sánchez-Gómez FJ, Pérez-Sala D [2004]. Protein modification by cyclopentenone prostaglandin addition: biological actions and therapeutic implications. Gene Ther Mol Biol 8: 241-258.
Sánchez-Gómez FJ, Cernuda-Morollón E, Stamatakis K, Pérez-Sala D [2004]. Protein thiol modification by 15-deoxy-D12,14-prostaglandin J2 addition in mesangial cells: role in the inhibition of proinflammatory genes. Mol Pharmacol 66: 1349-1358.
Pérez-Sala D, Cernuda-Morollón E, Cañada FJ [2003]. Molecular basis for the direct inhibition of AP-1 DNA binding by 15-deoxy-D12,14-prostaglandin J2. J Biol Chem 278: 51251-51260.
Oliva JL, Pérez-Sala D, Castrillo A, Martínez N, Cañada FJ, Boscá L, Rojas JM [2003]. The cyclopentenone 15-deoxy-D12,14-prostaglandin J2 binds to and activates H-Ras. Proc Natl Acad Sci USA 100: 4772-4777.
Stamatakis K, Cernuda-Morollón E, Hernández-Perera O, Pérez-Sala D [2002]. Isoprenylation of RhoB is necessary for its degradation: a novel determinant in the complex regulation of RhoB expression by the mevalonate pathway. J Biol Chem 277: 49389-49396.
Cernuda-Morollón E, Rodríguez-Pascual F, Klatt P, Lamas S, Pérez-Sala D [2002]. PPAR agonists amplify iNOS expression while inhibiting NF-kB: implications for mesangial cell activation by cytokines. J Am Soc Nephrol 13: 2223-2231.
